TrialThe New England journal of medicine2019
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.
Fernando C Fervenza et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
363 papers cite itlatest 60 shown
this paperpooled ittrialcites it